• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多参数直方图分析区分治疗后胶质母细胞瘤患者的肿瘤进展与假性进展

Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.

作者信息

Cha J, Kim S T, Kim H-J, Kim B-J, Kim Y K, Lee J Y, Jeon P, Kim K H, Kong D-S, Nam D-H

机构信息

From the Departments of Radiology and Center for Imaging Science (J.C., S.T.K., H.-J.K., B.-j.K., Y.K.K., J.Y.L., P.J., K.H.K.).

From the Departments of Radiology and Center for Imaging Science (J.C., S.T.K., H.-J.K., B.-j.K., Y.K.K., J.Y.L., P.J., K.H.K.)

出版信息

AJNR Am J Neuroradiol. 2014 Jul;35(7):1309-17. doi: 10.3174/ajnr.A3876. Epub 2014 Mar 27.

DOI:10.3174/ajnr.A3876
PMID:24676005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7966603/
Abstract

BACKGROUND AND PURPOSE

The multiparametric imaging can show us different aspects of tumor behavior and may help differentiation of tumor recurrence from treatment related change. Our aim was to differentiate tumor progression from pseudoprogression in patients with glioblastoma by using multiparametric histogram analysis of 2 consecutive MR imaging studies with relative cerebral blood volume and ADC values.

MATERIALS AND METHODS

Thirty-five consecutive patients with glioblastoma with new or increased size of enhancing lesions after concomitant chemoradiation therapy following surgical resection were included. Combined histograms were made by using the relative cerebral blood volume and ADC values of enhancing areas for initial and follow-up MR imaging, and subtracted histograms were also prepared. The histogram parameters between groups were compared. The diagnostic accuracy of tumor progression based on the histogram parameters of initial and follow-up MR imaging and subtracted histograms was compared and correlated with overall survival.

RESULTS

Twenty-four pseudoprogressions and 11 tumor progressions were determined. Diagnosis based on the subtracted histogram mode with a multiparametric approach was more accurate than the diagnosis based on the uniparametric approach (area under the receiver operating characteristic curve of 0.877 versus 0.801), with 81.8% sensitivity and 100% specificity. A high mode of relative cerebral blood volume on the subtracted histogram by using a multiparametric approach (relative cerebral blood volume ×ADC) was the best predictor of true tumor progression (P < .001) and worse survival (P = .003).

CONCLUSIONS

Multiparametric histogram analysis of posttreatment glioblastoma was useful to predict true tumor progression and worse survival.

摘要

背景与目的

多参数成像能够向我们展示肿瘤行为的不同方面,可能有助于鉴别肿瘤复发与治疗相关改变。我们的目的是通过对连续2次磁共振成像(MR)研究的相对脑血容量和表观扩散系数(ADC)值进行多参数直方图分析,来鉴别胶质母细胞瘤患者的肿瘤进展与假性进展。

材料与方法

纳入35例手术切除后同步放化疗后强化病灶新发或增大的胶质母细胞瘤患者。利用初始和随访MR成像强化区域的相对脑血容量和ADC值制作联合直方图,同时也制备相减直方图。比较组间直方图参数。比较基于初始和随访MR成像直方图参数及相减直方图的肿瘤进展诊断准确性,并与总生存期进行相关性分析。

结果

确定了24例假性进展和11例肿瘤进展。基于多参数方法的相减直方图模式诊断比基于单参数方法的诊断更准确(受试者操作特征曲线下面积分别为0.877和0.801),灵敏度为81.8%,特异性为100%。采用多参数方法(相对脑血容量×ADC)的相减直方图上相对脑血容量的高模式是真正肿瘤进展的最佳预测指标(P <.001),且与较差的生存期相关(P =.003)。

结论

治疗后胶质母细胞瘤的多参数直方图分析有助于预测真正的肿瘤进展和较差的生存期。

相似文献

1
Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.使用多参数直方图分析区分治疗后胶质母细胞瘤患者的肿瘤进展与假性进展
AJNR Am J Neuroradiol. 2014 Jul;35(7):1309-17. doi: 10.3174/ajnr.A3876. Epub 2014 Mar 27.
2
True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.治疗胶质母细胞瘤中的真性进展与假性进展:通过直方图分析比较归一化脑血容量和表观扩散系数。
Korean J Radiol. 2013 Jul-Aug;14(4):662-72. doi: 10.3348/kjr.2013.14.4.662. Epub 2013 Jul 17.
3
Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging.利用动态对比增强T1加权灌注磁共振成像得出的曲线下初始面积与最终面积之比预测胶质母细胞瘤患者的假性进展
AJNR Am J Neuroradiol. 2013 Dec;34(12):2278-86. doi: 10.3174/ajnr.A3634. Epub 2013 Jul 4.
4
Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.在接受放疗和替莫唑胺联合治疗的胶质母细胞瘤中,从假性进展中区分真性进展:标准和高 b 值扩散加权成像的对比研究。
Radiology. 2013 Dec;269(3):831-40. doi: 10.1148/radiol.13122024. Epub 2013 Oct 28.
5
Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.IVIM-DWI与3D-ASL联合用于鉴别多形性胶质母细胞瘤同步放化疗后真性进展与假性进展:一项前瞻性诊断试验的研究方案
BMC Med Imaging. 2017 Feb 1;17(1):10. doi: 10.1186/s12880-017-0183-y.
6
Differentiation of Recurrent Glioblastoma from Delayed Radiation Necrosis by Using Voxel-based Multiparametric Analysis of MR Imaging Data.基于体素的磁共振成像数据分析对复发性脑胶质母细胞瘤与迟发性放射性坏死的鉴别诊断。
Radiology. 2017 Oct;285(1):206-213. doi: 10.1148/radiol.2017161588. Epub 2017 May 23.
7
Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.原发性中枢神经系统淋巴瘤和非典型性脑胶质瘤:弥散、灌注和磁化率加权 MR 成像的多参数鉴别诊断。
Radiology. 2014 Sep;272(3):843-50. doi: 10.1148/radiol.14132740. Epub 2014 May 3.
8
Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value.胶质母细胞瘤患者放疗联合替莫唑胺治疗后真正进展的独立不良预后因素:室管膜下强化和低表观扩散系数值
AJNR Am J Neuroradiol. 2015 Oct;36(10):1846-52. doi: 10.3174/ajnr.A4401. Epub 2015 Aug 20.
9
Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.将弥散加权和灌注加权 MRI 纳入放射组学模型可提高胶质母细胞瘤患者假性进展的诊断性能。
Neuro Oncol. 2019 Feb 19;21(3):404-414. doi: 10.1093/neuonc/noy133.
10
Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.支持向量机多参数 MRI 鉴别切除后的胶质母细胞瘤患者肿瘤复发生物假进展。
J Magn Reson Imaging. 2011 Feb;33(2):296-305. doi: 10.1002/jmri.22432.

引用本文的文献

1
A hybrid [F]fluoropivalate PET-multiparametric MRI to detect and characterise brain tumour metastases based on a permissive environment for monocarboxylate transport.一种基于单羧酸转运的宽松环境的混合[F]氟新戊酸酯正电子发射断层扫描-多参数磁共振成像,用于检测和表征脑肿瘤转移灶。
Eur J Nucl Med Mol Imaging. 2025 Feb 7. doi: 10.1007/s00259-025-07118-0.
2
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.影像学在高级别胶质瘤的诊断、预后及治疗反应预测中的作用
J Med Signals Sens. 2024 Mar 27;14:7. doi: 10.4103/jmss.jmss_30_22. eCollection 2024.
3
Artificial Intelligence Analysis Using MRI and PET Imaging in Gliomas: A Narrative Review.使用MRI和PET成像的人工智能分析在胶质瘤中的应用:一项叙述性综述
Cancers (Basel). 2024 Jan 18;16(2):407. doi: 10.3390/cancers16020407.
4
Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.治疗后胶质瘤成像中的传统与先进成像技术
Front Radiol. 2022 Jun 28;2:883293. doi: 10.3389/fradi.2022.883293. eCollection 2022.
5
Disease Assessments in Patients with Glioblastoma.胶质母细胞瘤患者的疾病评估
Curr Oncol Rep. 2023 Sep;25(9):1057-1069. doi: 10.1007/s11912-023-01440-2. Epub 2023 Jul 20.
6
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study.定性和定量磁共振成像表型可预测异柠檬酸脱氢酶突变型星形细胞瘤中 CDKN2A/B 纯合缺失状态:一项多中心研究。
Korean J Radiol. 2023 Feb;24(2):133-144. doi: 10.3348/kjr.2022.0732.
7
Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence.弥散加权成像和动脉自旋标记放射组学特征可能有助于区分放射性脑损伤和胶质瘤复发。
Eur Radiol. 2023 May;33(5):3332-3342. doi: 10.1007/s00330-022-09365-3. Epub 2022 Dec 28.
8
Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma.铁补充剂对治疗后胶质母细胞瘤 MRI 评估的不良影响。
CNS Oncol. 2022 Dec 1;11(4):CNS90. doi: 10.2217/cns-2021-0018. Epub 2022 Nov 21.
9
Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression.灌注磁共振成像在胶质瘤复发与假性进展鉴别诊断中的应用:一项系统评价、Meta分析及Meta回归分析
Quant Imaging Med Surg. 2022 Oct;12(10):4805-4822. doi: 10.21037/qims-22-32.
10
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas.一种可解释的放射组学模型,用于选择手术后 WHO 分级 2 脑膜瘤患者进行放疗。
Radiat Oncol. 2022 Aug 22;17(1):147. doi: 10.1186/s13014-022-02090-7.

本文引用的文献

1
Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression.分析表观扩散系数(ADC)的分层模式,以区分放射性坏死与肿瘤进展。
Eur Radiol. 2013 Mar;23(3):879-86. doi: 10.1007/s00330-012-2638-4. Epub 2012 Aug 19.
2
Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas.灌注偏度和峰度的百分比变化:一种用于诊断为胶质母细胞瘤的患者的早期治疗反应的潜在影像学生物标志物。
Radiology. 2012 Sep;264(3):834-43. doi: 10.1148/radiol.12112120. Epub 2012 Jul 6.
3
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival.重新评估肿瘤进展的影像学定义:灌注 MRI 定量评估复发性脑胶质瘤肿瘤部分、假性进展和放射性坏死,以预测患者的生存情况。
Neuro Oncol. 2012 Jul;14(7):919-30. doi: 10.1093/neuonc/nos112. Epub 2012 May 3.
4
The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard.基于比较 MION 作为标准,探讨预加载和漏出校正在基于钆的脑血容量估计中的作用。
AJNR Am J Neuroradiol. 2012 Jun;33(6):1081-7. doi: 10.3174/ajnr.A2934. Epub 2012 Feb 9.
5
Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis?高级别胶质瘤的影像学检查方式:假性进展、复发还是坏死?
J Clin Neurosci. 2012 May;19(5):633-7. doi: 10.1016/j.jocn.2011.10.003. Epub 2012 Feb 8.
6
Double reading of radiological examinations in Norway.挪威放射学检查的双人阅片。
Acta Radiol. 2011 Jun 1;52(5):516-21. doi: 10.1258/ar.2011.100347. Epub 2011 Mar 17.
7
Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.假性进展和假性缓解:治疗后脑胶质瘤评估中的影像学挑战。
AJNR Am J Neuroradiol. 2011 Dec;32(11):1978-85. doi: 10.3174/ajnr.A2397. Epub 2011 Mar 10.
8
Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status.新诊断的胶质母细胞瘤治疗中的假性进展的诊断难题:评估相对脑血流容积和氧-6-甲基鸟嘌呤-DNA 甲基转移酶启动子甲基化状态的作用。
AJNR Am J Neuroradiol. 2011 Feb;32(2):382-7. doi: 10.3174/ajnr.A2286. Epub 2011 Jan 20.
9
Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence.治疗后高级别胶质瘤:半定量 MR 灌注直方图分析整个增强病变的峰值高度位置在预测复发体积分数中的作用。
Radiology. 2010 Sep;256(3):906-15. doi: 10.1148/radiol.10091461. Epub 2010 Jul 15.
10
Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.放疗联合替莫唑胺治疗 1 个月后脑组织相对血容量的变化有助于预测胶质母细胞瘤患者的总生存期。
Radiology. 2010 Aug;256(2):575-84. doi: 10.1148/radiol.10091440. Epub 2010 Jun 7.